Chennai Journal

Cholestatic Pruritus Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Escient Pharma, GlaxoSmithKline, Mirum Pharma, Albireo, Regeneron Pharma

DelveInsight’s “Cholestatic Pruritus Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Cholestatic Pruritus, historical and forecasted epidemiology as well as the Cholestatic Pruritus market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Cholestatic Pruritus market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Cholestatic Pruritus Market Forecast

Some of the key facts of the Cholestatic Pruritus Market Report: 

• The Cholestatic Pruritus market size is anticipated to grow with a significant CAGR during the study period (2019-2032)

• According to research conducted by Yoshikawa et al. in 2021, pruritus prevalence is documented at 70% among individuals with primary biliary cholangitis (PBC). Additionally, pruritus has been observed in 8% of patients with chronic hepatitis B and in approximately 2.5–20% of those with chronic hepatitis C.

• Pruritus is commonly linked to cholestatic liver conditions such as primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). Review articles suggest an occurrence of pruritus in approximately 20–70% of individuals with PBC and in 38% of those affected by PSC.

• Key Cholestatic Pruritus Companies: Escient Pharmaceuticals, GlaxoSmithKline, Mirum Pharmaceuticals, Albireo, Regeneron Pharmaceuticals, Avior Bio, and others

• Key Cholestatic Pruritus Therapies: EP547, Linerixibat, LUM001, A4250, Dupilumab, AV104, and others

• The Cholestatic Pruritus market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Cholestatic Pruritus pipeline products will significantly revolutionize the Cholestatic Pruritus market dynamics.

Cholestatic Pruritus Overview

Cholestatic pruritus, also known as cholestatic itch, is a distressing symptom characterized by intense itching that occurs in individuals with cholestatic liver diseases. Cholestatic liver diseases are conditions where the flow of bile from the liver to the small intestine is impaired, leading to the accumulation of bile acids and other substances in the bloodstream.

Get a Free sample for the Cholestatic Pruritus Market Forecast, Size & Share Analysis Report: 

https://www.delveinsight.com/report-store/cholestatic-pruritus-market

Cholestatic Pruritus Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Cholestatic Pruritus Epidemiology Segmentation:

The Cholestatic Pruritus market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

• Total Prevalence of Cholestatic Pruritus

• Prevalent Cases of Cholestatic Pruritus by severity

• Gender-specific Prevalence of Cholestatic Pruritus

• Diagnosed Cases of Episodic and Chronic Cholestatic Pruritus

Download the report to understand which factors are driving Cholestatic Pruritus epidemiology trends @ Cholestatic Pruritus Epidemiology Forecast

Cholestatic Pruritus Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Cholestatic Pruritus market or expected to get launched during the study period. The analysis covers Cholestatic Pruritus market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Cholestatic Pruritus Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Cholestatic Pruritus Therapies and Key Companies

• EP547: Escient Pharmaceuticals

• Linerixibat: GlaxoSmithKline

• LUM001: Mirum Pharmaceuticals

• A4250: Albireo

• Dupilumab: Regeneron Pharmaceuticals

• AV104: Avior Bio

Discover more about therapies set to grab major Cholestatic Pruritus market share @ Cholestatic Pruritus Treatment Landscape

Cholestatic Pruritus Market Strengths

• Increasing prevalence of Cholestatic Pruritus in the 7MM

• Complex underlying mechanisms have been identified and various therapeutic options developed.

Cholestatic Pruritus Market Opportunities

• Current treatments for cholestatic pruritus are inadequate, and additional, more effective therapeutic options are required.

Scope of the Cholestatic Pruritus Market Report

• Study Period: 2019–2032

• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

• Key Cholestatic Pruritus Companies: , and others

• Key Cholestatic Pruritus Therapies: EP547, Linerixibat, LUM001, A4250, Dupilumab, AV104, and others

• Cholestatic Pruritus Therapeutic Assessment: Cholestatic Pruritus current marketed and Cholestatic Pruritus emerging therapies

• Cholestatic Pruritus Market Dynamics: Cholestatic Pruritus market drivers and Cholestatic Pruritus market barriers 

• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

• Cholestatic Pruritus Unmet Needs, KOL’s views, Analyst’s views, Cholestatic Pruritus Market Access and Reimbursement 

To know more about Cholestatic Pruritus companies working in the treatment market, visit @ Cholestatic Pruritus Clinical Trials and Therapeutic Assessment

Table of Contents 

1. Cholestatic Pruritus Market Report Introduction

2. Executive Summary for Cholestatic Pruritus

3. SWOT analysis of Cholestatic Pruritus

4. Cholestatic Pruritus Patient Share (%) Overview at a Glance

5. Cholestatic Pruritus Market Overview at a Glance

6. Cholestatic Pruritus Disease Background and Overview

7. Cholestatic Pruritus Epidemiology and Patient Population

8. Country-Specific Patient Population of Cholestatic Pruritus 

9. Cholestatic Pruritus Current Treatment and Medical Practices

10. Cholestatic Pruritus Unmet Needs

11. Cholestatic Pruritus Emerging Therapies

12. Cholestatic Pruritus Market Outlook

13. Country-Wise Cholestatic Pruritus Market Analysis (2019–2032)

14. Cholestatic Pruritus Market Access and Reimbursement of Therapies

15. Cholestatic Pruritus Market Drivers

16. Cholestatic Pruritus Market Barriers

17.  Cholestatic Pruritus Appendix

18. Cholestatic Pruritus Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/